202 related articles for article (PubMed ID: 30251898)
21. Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo.
Więckowska A; Więckowski K; Bajda M; Brus B; Sałat K; Czerwińska P; Gobec S; Filipek B; Malawska B
Bioorg Med Chem; 2015 May; 23(10):2445-57. PubMed ID: 25868744
[TBL] [Abstract][Full Text] [Related]
22. Sulfonamides as multifunctional agents for Alzheimer's disease.
Bag S; Tulsan R; Sood A; Cho H; Redjeb H; Zhou W; LeVine H; Török B; Török M
Bioorg Med Chem Lett; 2015 Feb; 25(3):626-30. PubMed ID: 25537270
[TBL] [Abstract][Full Text] [Related]
23. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor.
Sugimoto H; Ogura H; Arai Y; Limura Y; Yamanishi Y
Jpn J Pharmacol; 2002 May; 89(1):7-20. PubMed ID: 12083745
[TBL] [Abstract][Full Text] [Related]
24. Metformin and Its Sulfenamide Prodrugs Inhibit Human Cholinesterase Activity.
Markowicz-Piasecka M; Sikora J; Mateusiak Ł; Mikiciuk-Olasik E; Huttunen KM
Oxid Med Cell Longev; 2017; 2017():7303096. PubMed ID: 28770024
[TBL] [Abstract][Full Text] [Related]
25. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
[TBL] [Abstract][Full Text] [Related]
26. Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates.
Viayna E; Gómez T; Galdeano C; Ramírez L; Ratia M; Badia A; Clos MV; Verdaguer E; Junyent F; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Camps P; Muñoz-Torrero D
ChemMedChem; 2010 Nov; 5(11):1855-70. PubMed ID: 20859987
[TBL] [Abstract][Full Text] [Related]
27. Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease.
Wang ZM; Cai P; Liu QH; Xu DQ; Yang XL; Wu JJ; Kong LY; Wang XB
Eur J Med Chem; 2016 Nov; 123():282-297. PubMed ID: 27484514
[TBL] [Abstract][Full Text] [Related]
28. Dual targeting of cholinesterase and amyloid beta with pyridinium/isoquinolium derivatives.
Chakravarty H; Ju Y; Chen WH; Tam KY
Drug Dev Res; 2020 Apr; 81(2):242-255. PubMed ID: 31837041
[TBL] [Abstract][Full Text] [Related]
29. Modulatory effect of caffeic acid on cholinesterases inhibitory properties of donepezil.
Agunloye OM; Oboh G
J Complement Integr Med; 2017 Sep; 15(1):. PubMed ID: 28941354
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationship studies of benzyl-, phenethyl-, and pyridyl-substituted tetrahydroacridin-9-amines as multitargeting agents to treat Alzheimer's disease.
Osman W; Mohamed T; Sit VM; Vasefi MS; Beazely MA; Rao PP
Chem Biol Drug Des; 2016 Nov; 88(5):710-723. PubMed ID: 27282589
[TBL] [Abstract][Full Text] [Related]
31. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.
Ye CY; Lei Y; Tang XC; Zhang HY
Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
[TBL] [Abstract][Full Text] [Related]
33. Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide 25-35 and Cholinesterase Inhibitory Property of Its Bioactive Compounds.
Shanmuganathan B; Sheeja Malar D; Sathya S; Pandima Devi K
PLoS One; 2015; 10(11):e0141708. PubMed ID: 26536106
[TBL] [Abstract][Full Text] [Related]
34. DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against Aβ-induced neuronal damage via the Akt/JNK signaling pathway.
Zhou D; Zhou W; Song JK; Feng ZY; Yang RY; Wu S; Wang L; Liu AL; Du GH
Acta Pharmacol Sin; 2016 Nov; 37(11):1401-1412. PubMed ID: 27498773
[TBL] [Abstract][Full Text] [Related]
35. Quetiapine and novel PDE10A inhibitors potentiate the anti-BuChE activity of donepezil.
Sikora J; Podsiedlik M; Pietras T; Kosmalski M; Matłoka M; Moszczyński-Petkowski R; Wieczorek M; Markowicz-Piasecka M
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1743-1750. PubMed ID: 32938236
[TBL] [Abstract][Full Text] [Related]
36. Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.
Czarnecka K; Chufarova N; Halczuk K; Maciejewska K; Girek M; Skibiński R; Jończyk J; Bajda M; Kabziński J; Majsterek I; Szymański P
Eur J Med Chem; 2018 Feb; 145():760-769. PubMed ID: 29353726
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors.
Hu Y; Zhang J; Chandrashankra O; Ip FC; Ip NY
Bioorg Med Chem; 2013 Feb; 21(3):676-83. PubMed ID: 23273608
[TBL] [Abstract][Full Text] [Related]
38. Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.
Nordberg A; Darreh-Shori T; Peskind E; Soininen H; Mousavi M; Eagle G; Lane R
Curr Alzheimer Res; 2009 Feb; 6(1):4-14. PubMed ID: 19199870
[TBL] [Abstract][Full Text] [Related]
39. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
[TBL] [Abstract][Full Text] [Related]
40. Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil.
van Greunen DG; Cordier W; Nell M; van der Westhuyzen C; Steenkamp V; Panayides JL; Riley DL
Eur J Med Chem; 2017 Feb; 127():671-690. PubMed ID: 27823887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
